Rapport Therapeutics offers convertible senior notes due 2032, size not disclosed
RAPP•Rapport Therapeutics offered convertible senior notes due 2032, according to an SEC filing. The offering size was not disclosed.
1. Notes offering
Rapport Therapeutics offered convertible senior notes due 2032, according to an SEC filing. The size of the offering was not disclosed.
